XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 12, 2023
Dec. 11, 2023
Product Information [Line Items]                  
Net loss $ (2,074,874) $ (6,875,640)   $ (690,070) $ (13,643,995)        
Assets 73,564,702     73,564,702   $ 72,460,026      
Liabilities 73,182,322     73,182,322   76,505,394      
Revenue performance obligation $ 58,684,740 48,490,126   $ 123,208,298 88,709,454        
Subscription price per share $ 1.95     $ 1.95          
Deferred revenue $ 11,800,000     $ 11,800,000   14,500,000      
Deferred revenue           12,500,000      
Sales returns and allowances 832,000     832,000   894,000      
Inventory reserve 153,464     153,464   263,320      
Deposits assets, current 251,000     251,000   40,763      
Purchase obligation 616,000     616,000          
Capitalized software costs $ 14,837,946     $ 14,837,946   $ 13,816,501      
Fulfillment Services [Member] | Supplier Concentration Risk [Member] | Vendors [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       70.00%   98.00%      
Prescription Medications [Member] | Supplier Concentration Risk [Member] | Vendors [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       14.00%   10.00%      
Minimum [Member]                  
Product Information [Line Items]                  
Percentage of interest-bearing domestic deposits 10.00%     10.00%          
Intangible assets, term 1 year     1 year          
Maximum [Member]                  
Product Information [Line Items]                  
Percentage of interest-bearing domestic deposits 33.00%     33.00%          
Intangible assets, term 10 years     10 years          
Product and Services [Member]                  
Product Information [Line Items]                  
Revenue performance obligation $ 3,600,000 389,000   $ 7,500,000 392,000        
Product [Member]                  
Product Information [Line Items]                  
Customer discounts and allowance 1,600,000 1,800,000   2,400,000 2,800,000        
Software Revenue [Member]                  
Product Information [Line Items]                  
Customer discounts and allowance 900,000 676,000   2,000,000.0 1,400,000        
TeleHealth in Process [Member]                  
Product Information [Line Items]                  
Accrued contract liabilities 7,500,000     7,500,000   $ 10,100,000      
Accrued contract liabilities 1,900,000     1,900,000   1,900,000      
WorkSimpli in Process [Member]                  
Product Information [Line Items]                  
Accrued contract liabilities 2,400,000     2,400,000   2,500,000      
LifeMD PC [Member]                  
Product Information [Line Items]                  
Net loss 3,400,000 3,600,000   6,700,000 $ 6,000,000.0        
Assets 7,000     7,000   8,000      
Liabilities $ 259,000     $ 259,000   380,000      
Medifast Inc [Member]                  
Product Information [Line Items]                  
Transaction amount           $ 10,000,000   $ 5,000,000 $ 10,000,000
Consideration to be transferred   2,500,000 $ 2,500,000            
Transaction amount collected   $ 3,000,000 $ 2,000,000       $ 5,000,000